Clinical Trial Update: Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating atezolizumab with pemetrexed disodium and cisplatin, followed by surgery with or without radiation, for Stage I–III malignant pleural m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biphasic Malignant Pleural Mesothelioma
• Epithelioid Malignant Pleural Mesothelioma
• Malignant Pleural Mesothelioma

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)
• Tecentriq (atezolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Biphasic Mesothelioma, Epithelioid Mesothelioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-03-05